Genetic variants of CD160, MERTK, and IL15 in natural killer cell-related pathway predict gastric cancer survival.
Saved in:
| Title: | Genetic variants of CD160, MERTK, and IL15 in natural killer cell-related pathway predict gastric cancer survival. |
|---|---|
| Authors: | Zeng G; Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, China., Lu G; Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, China., Hu B; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Xu M; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China., Li G; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China., Wang M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China., Qiu L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhang R; Department of Epidemiology, School of Public Health; Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China., Cheng L; Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Xu W; Department of Epidemiology, School of Public Health; Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China., Liu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China., Jin G; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Liu H; Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, China., Wei Q; Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, China.; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 15; Vol. 17, pp. 1765825. Date of Electronic Publication: 2026 Apr 15 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1765825 |
